New warnings are raising controversy about the use of antidepressants

December 2004

New warnings are raising controversy about the use of antidepressants...especially in children and teens.

A new black box warning will be added to antidepressant labeling...and every patient will get a "Medication Guide."

The FDA is concerned about an increased risk of suicidal thinking or behavior in some kids...especially when starting antidepressant therapy...or changing the dose.

Get concise, unbiased advice for effective drug therapy, plus CE/CME

Prescriber's Letter includes:

  • 12 issues every year, with brief articles about new meds and guidelines
  • 48+ CE courses, including the popular CE-in-the-Letter
  • Quick reference drug comparison charts
  • Access to the entire archive

Already a subscriber? Log in

Volume pricing available. Get a quote